TY - JOUR
T1 - Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma
AU - Larsen, Gary L.
AU - Morgan, Wayne
AU - Heldt, Gregory P.
AU - Mauger, David T.
AU - Boehmer, Susan J.
AU - Chinchilli, Vernon M.
AU - Lemanske, Robert F.
AU - Martinez, Fernando
AU - Strunk, Robert C.
AU - Szefler, Stanley J.
AU - Zeiger, Robert S.
AU - Taussig, Lynn M.
AU - Bacharier, Leonard B.
AU - Guilbert, Theresa W.
AU - Radford, Shelley
AU - Sorkness, Christine A.
PY - 2009/4
Y1 - 2009/4
N2 - Background: Determination of the benefits and limitations of specific physiologic tests has not been well studied in long-term clinical pediatric trials. Objective: We sought to determine the utility of impulse oscillometry in a long-term comparison of 3 controller regimens in children with persistent asthma. Methods: Children 6 to 14 years of age with mild-to-moderate persistent asthma were characterized with oscillometry and spirometry before entry into a clinical trial and then serially during 48 weeks of therapy with either an inhaled corticosteroid, a combination inhaled corticosteroid with a long-acting β-agonist, or a leukotriene receptor antagonist. Results: The FEV1/forced vital capacity ratio, as well as the forced expiratory flow from 25% to 75% of forced vital capacity in terms of spirometric parameters and the reactance area (XA) from impulse oscillometry, appeared to complement information provided by FEV1 when comparing the tests and factors that appeared to predict a response to treatment. XA was unique in that it, as distinct from spirometric variables, reflected ongoing improvement during the latter part of the trial. In general, improvements in XA during the latter part of the study occurred independently of indices of atopy and the level of airway responsiveness. Conclusion: Assessment of respiratory mechanics over time with oscillometry might offer additional insights into the response of asthmatic patients to therapy. In particular, the pattern of improvement seen in XA over the course of therapy suggests this test might detect alterations in airway mechanics not reflected by spirometry. The possibility that changes in XA reflect ongoing improvement in small airway function deserves additional study.
AB - Background: Determination of the benefits and limitations of specific physiologic tests has not been well studied in long-term clinical pediatric trials. Objective: We sought to determine the utility of impulse oscillometry in a long-term comparison of 3 controller regimens in children with persistent asthma. Methods: Children 6 to 14 years of age with mild-to-moderate persistent asthma were characterized with oscillometry and spirometry before entry into a clinical trial and then serially during 48 weeks of therapy with either an inhaled corticosteroid, a combination inhaled corticosteroid with a long-acting β-agonist, or a leukotriene receptor antagonist. Results: The FEV1/forced vital capacity ratio, as well as the forced expiratory flow from 25% to 75% of forced vital capacity in terms of spirometric parameters and the reactance area (XA) from impulse oscillometry, appeared to complement information provided by FEV1 when comparing the tests and factors that appeared to predict a response to treatment. XA was unique in that it, as distinct from spirometric variables, reflected ongoing improvement during the latter part of the trial. In general, improvements in XA during the latter part of the study occurred independently of indices of atopy and the level of airway responsiveness. Conclusion: Assessment of respiratory mechanics over time with oscillometry might offer additional insights into the response of asthmatic patients to therapy. In particular, the pattern of improvement seen in XA over the course of therapy suggests this test might detect alterations in airway mechanics not reflected by spirometry. The possibility that changes in XA reflect ongoing improvement in small airway function deserves additional study.
UR - http://www.scopus.com/inward/record.url?scp=63449107671&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63449107671&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2008.10.036
DO - 10.1016/j.jaci.2008.10.036
M3 - Article
C2 - 19070356
AN - SCOPUS:63449107671
SN - 0091-6749
VL - 123
SP - 861-867.e1
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 4
ER -